The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
Mike Gillett, Alan Brennan, Penny Watson, Kamlesh Khunti, Melanie Davies, Samiul Mostafa, Laura J Gray
Health Technology Assessment | NIHR JOURNALS LIBRARY | Published : 2015
BACKGROUND: An estimated 850,000 people have diabetes without knowing it and as many as 7 million more are at high risk of developing it. Within the NHS Health Checks programme, blood glucose testing can be undertaken using a fasting plasma glucose (FPG) or a glycated haemoglobin (HbA1c) test but the relative cost-effectiveness of these is unknown. OBJECTIVES: To estimate and compare the cost-effectiveness of screening for type 2 diabetes using a HbA1c test versus a FPG test. In addition, to compare the use of a random capillary glucose (RCG) test versus a non-invasive risk score to prioritise individuals who should undertake a HbA1c or FPG test. DESIGN: Cost-effectiveness analysis using the..View full abstract
Awarded by National Institute for Health Research
The National Institute for Health Research Health Technology Assessment programme.